secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2024-12-30T23:59:59+00:00
Accession:  0001104659-24-132569
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.01
LLM model:  deepseek-v4-flash:cloud@v2

Novavax completes $200M sale of Czech manufacturing campus to Novo Nordisk
--------------------------------------------------------------------------

- Total purchase price $200M; $180M cash at close, $10M paid Sept 2024, $10M escrow for 12 months.
- Seller also received ~$2.6M reimbursement for operating costs between Dec 3 and closing.
- Novavax sold its Bohumil, Jevany facility including land, movable assets, contracts, and employees.
- Transaction closed Dec 30, 2024; Novo Nordisk Production Czech s.r.o. is the purchaser.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000110465924132569/0001104659-24-132569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000110465924132569/tm2432218d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-132569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer